$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
What does dacomitinib do? Are there any side effects?
2025-10-19 11:44:20
Check Details
Does the third-generation targeted drug for lung cancer, lorlatinib, have any side effects? What should we pay attention to
2025-10-19 11:44:20
Check Details
The FDA has approved the bispecific antibody Rybrevant for marketing. What are the efficacy and side effects of Rybrevant?
2025-10-19 11:44:20
Check Details
Does ramucirumab have serious side effects? What should we pay attention to?
2025-10-19 11:44:20
Check Details
Effects and side effects of Tepotinib Hydrochloride Tablets
2025-10-19 11:44:20
Check Details
Efficacy and side effects of serpatinib, a new drug for non-small cell lung cancer
2025-10-19 11:44:20
Check Details
What should I do if I have a bad appetite after taking gefitinib? What are the side effects of gefitinib?
2025-10-19 11:44:20
Check Details
What are the side effects of afatinib? How to deal with the side effects of afatinib?
2025-10-19 11:44:20
Check Details
What are the side effects of Lumakras, the world’s first KRAS targeted therapy? What's the price?
2025-10-19 11:44:20
Check Details
How long does it take for erlotinib rash to subside? How much does a box of erlotinib cost in Beijing?
2025-10-19 11:44:20
Check Details
Do you know the precautions and side effects of using serpatinib?
2025-10-19 11:44:20
Check Details
Will the side effects of ceritinib disappear? How to take ceritinib effectively?
2025-10-19 11:44:20
Check Details
1
2
...
10147
10148
10149
10150
10151
10152
10153
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma